mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0005 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.005 |
mRNA |
Parthenolide |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
0.005 |
mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.006 |
mRNA |
BRD-K79669418 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.006 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.006 |
mRNA |
BRD-K99584050 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.009 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.009 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.01 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.01 |